Leading critical environment air quality management company looks for startups in two applications to address market needs resulting from COVID-19.
1. Airborne particulate matter counting and identification
2. New Air Disinfection and Monitoring Technology
Erik Vogan, PhD, MBA, Program Director, MIT Corporate Relations Industrial Liaison Program
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
The 2026 MIT Enterprise AI Forum will spotlight cutting‑edge Enterprise AI strategies, practical frameworks, and breakthrough applications across mission‑critical domains such as real-time digital twins, automated defect detection, and intelligent product lifecycle management.
Max Kanter, Cofounder & CEO, Feature Labs